Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Collegium Pharmaceutical, Inc.
COLL
Lease impairment
Lease impairment at other companies
Boston Beer
SAM
$150K
—
BankUnited
BKU
$51.75K
+283%
Tetra Tech
TTEK
$0
—
Zymeworks
ZYME
$79K
—
Strategic Education, Inc.
STRA
$233K
+195%
Target Hospitality
TH
$0
—
Segments
By geography
See full
Durham, North Carolina
$575K
—
Other financials
Income statement
See full
Revenue
$193.5M
+8.9%
Gross profit
$117.2M
+20.5%
Operating income
$30.9M
+42.5%
Net income
$14.5M
+500%
EPS (diluted)
$0.40
+471%
Balance sheet
See full
Cash & equivalents
$289.6M
+147%
Total debt
$5.2M
-19.5%
Total equity
$312.4M
+33.3%
Total assets
$1.7B
+1.3%
Cash flow
See full
Operating cash flow
$57.1M
+3.1%
CapEx
$270.0K
-66.2%
Free cash flow
$56.8M
+4.1%
Valuation
See full
Market cap
$1.15B
+17.9%
Enterprise value
$869.67M
-0.3%
P/E
15.4×
-6.9×
P/S
1.5×
0.0×
Profitability
See full
Gross margin
60.7%
+3.0pp
Operating margin
23.7%
+2.3pp
Net margin
9.4%
+2.8pp
FCF margin
41.4%
+10.4pp
Returns & leverage
See full
Return on equity
27.4%
+8.2pp
Debt / equity
0×
0.0×
Current ratio
1.7×
+0.6×